Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders

Medical Hypotheses
Mark F McCarty

Abstract

Chronic neurodegenerative disorders are characterized by activation of microglia in the affected neural pathways. Peroxynitrite, prostanoids, and cytokines generated by these microglia can potentiate the excitotoxicity that contributes to neuronal death and dysfunction in these disorders--both by direct effects on neurons, and by impairing the capacity of astrocytes to sequester and metabolize glutamate. This suggests a vicious cycle in which the death of neurons leads to microglial activation, which in turn potentiates neuronal damage. If this model is correct, measures which down-regulate microglial activation may have a favorable effect on the induction and progression of neurodegenerative disease, independent of the particular trigger or target involved in a given disorder. Consistent with this possibility, the antibiotic minocycline, which inhibits microglial activation, shows broad utility in rodent models of neurodegeneration. Other agents which may have potential in this regard include PPARgamma agonists, genistein, vitamin D, COX-2 inhibitors, statins (and possibly policosanol), caffeine, cannabinoids, and sesamin; some of these agents could also be expected to be directly protective to neurons threatened with excitoto...Continue Reading

References

Jul 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·N KoketsuT Shimizu
May 25, 1991·European Journal of Pharmacology·M H Bureau, R W Olsen
Nov 1, 1991·Acta Neurologica Scandinavica·T A Treves, J de Pedro-Cuesta
Feb 1, 1987·Neuropharmacology·R G Fariello, G T Golden
Mar 1, 1983·Clinical Neuropharmacology·L Durelli, R Mutani
Mar 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H OoboshiM Fujishima
Jun 1, 1994·Journal of Neuroscience Research·I NeveuM Garabédian
Oct 1, 1993·International Journal of Epidemiology·E J Betemps, C R Buncher
Mar 15, 1996·The Journal of Biological Chemistry·D TrottiA Volterra
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y XiaJ L Zweier
Dec 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M A VirmaniE Arrigoni-Martelli
Dec 12, 1995·European Journal of Pharmacology·P PopoliG Ricciarello
Jan 1, 1997·Free Radical Biology & Medicine·L PackerK Wessel
Feb 1, 1997·European Journal of Biochemistry·M K BauerB L Fiebich
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·S ChristenB N Ames
May 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H HaraM A Moskowitz
Sep 26, 1997·Neurology·G LogroscinoR Mayeux
Dec 10, 1997·Annals of Neurology·S KalmijnM M Breteler
May 23, 1998·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·E NiederwolfsgruberB Grubeck-Loebenstein
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M EndresJ K Liao
Oct 3, 1998·Brain Research·P Saransaari, S S Oja
Dec 5, 1998·Biochemical and Biophysical Research Communications·Y M KuoA E Roher
Apr 10, 1999·Mechanisms of Ageing and Development·R DawsonT Patterson
May 18, 1999·Biochemical and Biophysical Research Communications·V N Trieu, F M Uckun

❮ Previous
Next ❯

Citations

Jun 1, 2012·Journal of Caffeine Research·Inmaculada Ballesteros-YáñezMairena Martín
Jun 16, 2009·Canadian Journal of Physiology and Pharmacology·Kyong Nyon NamEunjoo H Lee
Dec 5, 2006·Current Opinion in Clinical Nutrition and Metabolic Care·Allan V Kalueff, Pentti Tuohimaa
Dec 22, 2015·Neurotoxicology·Long-Long YangGui-Rong Ding
Jan 1, 2013·Comparative Immunology, Microbiology and Infectious Diseases·Ji-Nan SheuHung-Ming Chang
Mar 14, 2013·Journal of Neuropathology and Experimental Neurology·Ingrid MoralesManuel Rodriguez
Sep 22, 2010·European Journal of Pharmacology·Kyong Nyon NamEunjoo H Lee
Feb 4, 2010·International Immunopharmacology·Kyong Nyon NamEunjoo H Lee
Jun 17, 2008·The Journal of Nutritional Biochemistry·Angeles Fernández-ArcheValentina Ruiz-Gutierrez
Jun 10, 2008·European Journal of Pharmacology·Kyong Nyon NamEunjoo H Lee
Aug 31, 2007·Brain Research·Kyung-Hee LeeEunjoo H Lee
Sep 8, 2007·Neurobiology of Disease·Monica Garcia-AllozaBrian J Bacskai
Feb 27, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Niraj Ahuja, Brendan T Carroll
Apr 17, 2007·Experimental Neurology·Ennio EspositoGiuseppe Di Giovanni
Oct 15, 2013·Biochimica Et Biophysica Acta·Aaron M SwomleyD Allan Butterfield
Aug 19, 2014·Mediators of Inflammation·Ana R SantiagoCatarina A Gomes
Feb 22, 2012·Pharmacology, Biochemistry, and Behavior·Se Jin ParkJong Hoon Ryu
Nov 26, 2013·Biochemical and Biophysical Research Communications·Ajit G ThomasBarbara S Slusher
May 16, 2009·Brain Research·Yoko S KanekoAkira Ota
Oct 22, 2010·Journal of Pharmacological Sciences·Andrea DonzelliMariaelvina Sala
Feb 4, 2012·Neuro-degenerative Diseases·Yoko S KanekoAkira Ota
Jun 15, 2007·Expert Review of Neurotherapeutics·Ennio EspositoGiuseppe Di Giovanni
Jun 24, 2017·Journal of Chemical Neuroanatomy·Sachchida Nand RaiSurya Pratap Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes & Huntington’s Disease (MDS)

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.